We seek out innovation around the globe and bring together best-in-class partners who share our vision of
delivering world-class medicines to patients. We design partnerships that marry the strengths and
capabilities of each organization to rapidly turn promising science into new medicines.
Our priority is to invest in clinical stage assets with demonstrated efficacy, or portfolios where multiple
product opportunities and synergies exist. We are also interested in cutting-edge platforms where multiple
products can be rapidly discovered and developed.